Drug repurposing emerges as viable option for rare disease treatment
With few options available for the treatment of rare diseases, the practice of drug repurposing…
Diving into the intricacies of the current trends and challenges of the biotech industry.
With few options available for the treatment of rare diseases, the practice of drug repurposing…
Scientists are increasingly realizing the potential of biomaterials to help with many tasks. A key…
The companies Apogee Therapeutics, Pulmocide and Qitan Technology bagged the biggest biotech investments in December…
New cancer drugs are entering the market every year, but it’s hard to know which…
2022 is coming to an end. Here is a list of biotech companies from around…
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs)…
The companies Emalex Biosciences, Osler Diagnostics and TauRx Pharmaceuticals bagged the biggest biotech investments in…
HIV research has come a long way since the virus was discovered in the…
Gene editing has come far in the past decade. However, the field is still finding…
The companies Tempus Labs, Oculis and VectorBuilder Biotechnology bagged the biggest biotech investments in October…
Companies in the cell and gene therapy space are struggling to raise investments amid adverse…